Calcific atherosclerosis is a condition where calcium deposits build up inside the walls of your arteries, specifically within fatty plaques that have accumulated over time. It represents an advanced stage of atherosclerosis, the gradual narrowing and hardening of arteries that drives most heart attacks and strokes. Nearly everyone develops some degree of arterial calcification with age, but how much you have, and how quickly it progresses, tells a lot about your cardiovascular risk.
How Calcium Ends Up in Your Arteries
Atherosclerosis starts when cholesterol and other fats slip beneath the inner lining of an artery and trigger inflammation. White blood cells rush in, and over years, a plaque of fat, immune cells, and scar tissue forms. At some point, the smooth muscle cells in the artery wall begin to change. Normally, these cells contract and relax to control blood flow. But under the stress of a growing plaque, they start behaving more like bone-forming cells, producing minerals and laying down calcium in the surrounding tissue.
This transformation happens in phases. First, the smooth muscle cells shift their internal programming in response to inflammatory signals. Within days, they begin producing an enzyme normally active in bone growth. Over weeks, they generate tiny mineral-filled packets that seed calcium crystals into the plaque. The result is a process strikingly similar to how your skeleton builds bone, except it’s happening where it shouldn’t be.
It’s worth noting that calcium deposits in arteries show up in two distinct locations. In calcific atherosclerosis, the calcium sits in the inner layer of the artery wall (the intima), mixed in with fat and immune cells. A separate type of calcification affects the middle layer (the media) and is more common in people with diabetes or kidney disease. Both types stiffen arteries, but they arise from different triggers and carry different implications.
Why It Matters for Your Heart
Calcification makes arteries stiffer and less elastic. Healthy arteries expand slightly with each heartbeat to absorb pressure, then spring back. When calcium hardens the walls, that cushioning effect disappears. Your heart has to pump harder against rigid pipes, which raises blood pressure and increases strain on the heart muscle over time.
The relationship between calcification and dangerous events like heart attacks is nuanced. Heavily calcified plaques are actually more stable in some ways: the calcium acts like a hard shell that resists rupture. The plaques most likely to burst open and cause a sudden heart attack tend to be softer, with a thin cap over a pool of fatty debris. But the total amount of calcium in your coronary arteries is still one of the strongest predictors of future heart problems, because it reflects the overall burden of disease. People with coronary calcium scores above 300 face 10-year cardiac event rates as high as 13% to 26%.
Who Gets It and When
Calcific atherosclerosis becomes increasingly common with age, but it isn’t exclusive to older adults. Among people aged 30 to 45, about 21% already have detectable coronary calcium. Men develop it earlier and more extensively than women: 25% of men in that age range have some calcium, compared to 9% of women. For a woman under 45, any detectable calcium automatically places her above the 90th percentile for her age group, making it a particularly strong warning sign.
The standard risk factors for atherosclerosis all accelerate calcification: high blood pressure, smoking, high cholesterol, diabetes, and a sedentary lifestyle. But certain conditions push the process much further. Chronic kidney disease is one of the most potent accelerators. When the kidneys can’t properly regulate calcium and phosphate levels in the blood, excess minerals flood the bloodstream and deposit in vessel walls. The impaired kidneys also fail to clear inflammatory signals, and the resulting oxidative stress compounds the damage. People with advanced kidney disease often have calcification far more severe than their age would predict.
Measuring It: The Calcium Score
A coronary artery calcium (CAC) scan uses a quick, low-dose CT scan of your chest to detect and quantify calcium in the arteries feeding your heart. The result is an Agatston score, a number that reflects both the amount and density of calcium present.
- Score of 0: No detectable calcium. Very low short-term risk of a coronary event.
- Score of 1 to 99: Mild calcification. Atherosclerosis is present but limited.
- Score of 100 to 300: Moderate calcification. Elevated risk that typically warrants closer attention to risk factors.
- Score above 300: Extensive calcification and significantly higher event rates over the next decade.
- Score above 1,000: Severe disease. These individuals receive the most aggressive preventive treatment.
The 2019 ACC/AHA guidelines on cardiovascular prevention recommend considering a calcium score scan for adults aged 40 to 75 when the decision to start preventive medication isn’t clear-cut. It’s most useful for people whose estimated 10-year heart disease risk falls in a borderline or intermediate range, where the result can tip the balance toward or away from treatment. Adding the calcium score to traditional risk factors significantly improves the accuracy of predicting who will actually have a cardiac event, as confirmed by data from the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study.
How Treatment Affects Calcification
Here’s something that surprises many people: cholesterol-lowering statin therapy actually increases your calcium score, even as it lowers your overall risk of a heart attack. This isn’t a contradiction. Statins work in part by transforming dangerous, soft, rupture-prone plaques into denser, more heavily calcified ones. The fatty and inflammatory components of the plaque shrink while the calcium content increases, essentially turning a volatile lesion into something more inert and stable.
Research from the American College of Cardiology shows that statin-treated plaques develop higher-density calcium and lose their low-density fatty material. Plaques with very dense calcium (above 1,000 Hounsfield units on a CT scan) are associated with lower rates of major cardiac events. So a rising calcium score on statins doesn’t mean the disease is getting worse. It means the plaques are hardening into a less dangerous form. The overall plaque volume also progresses more slowly in statin-treated patients, particularly in lesions that have already calcified.
For arteries that have become so calcified they resist standard treatments like balloon angioplasty or stent placement, newer techniques can help. Intravascular lithotripsy delivers targeted shockwaves inside the artery to crack rigid calcium deposits, making the vessel flexible enough to open with a stent. In clinical studies, this approach reduced blockages effectively with no major complications, and roughly 77% of calcified nodules showed visible deformation after treatment.
The Role of Vitamin K
Your body has a built-in defense against arterial calcification: a protein called matrix Gla protein (MGP), which acts as a local inhibitor of mineralization in blood vessel walls. But MGP only works when it’s been activated by vitamin K. Without enough vitamin K, the protein remains inactive and can’t do its job.
Vitamin K comes in two main forms. Vitamin K1 is found in leafy green vegetables like spinach and kale. Vitamin K2, found in fermented foods like certain cheeses and natto (a fermented soybean product common in Japan), may be more relevant to vascular health because it’s more readily used in tissues outside the liver. Getting adequate vitamin K through diet supports the activation of this protective protein, though the degree to which supplementation can slow or reverse existing calcification in humans remains an active area of investigation.
Conditions That Accelerate Calcification
Beyond the usual cardiovascular risk factors, several conditions create an environment where calcification progresses faster. Chronic kidney disease stands out as the most significant. When kidney function declines, phosphate builds up in the blood because the kidneys can no longer excrete it efficiently. Elevated phosphate directly stimulates smooth muscle cells to adopt that bone-like behavior. At the same time, the body’s parathyroid hormone levels rise in an attempt to rebalance calcium and phosphate, but this hormonal disruption can itself promote calcium deposition in soft tissues.
Diabetes accelerates both intimal and medial calcification. The combination of high blood sugar, insulin resistance, and the chronic inflammation that accompanies diabetes creates a particularly hostile environment for blood vessels. People with both diabetes and kidney disease face compounded risk, and vascular calcification in these patients is associated with significantly higher rates of cardiovascular illness and death.